The clinic that owns you
Most independent clinics aren’t really businesses. They’re jobs with good branding. The income is tied to the owner’s hands and hours — stop working, and it stops. There’s no recurring base, nothing that compounds in the background. And when it’s time to sell, the market is brutally honest about what that’s worth.
What a clinic is actually worth (and why it’s so low)
A practice built on the owner’s time sells for a multiple of its furniture, not its future. The data is blunt: small, owner-operated medical practices typically change hands at roughly 2–4× EBITDA — primary-care practices sit around 2.61–3.61×, and chiropractic clinics around 2.86–3.83× in the transaction databases. (Peak Business Valuation, 2023–2024) Broader M&A data shows roughly 3–7× for smaller clinics, climbing toward 10–15× only for larger, multi-site groups with more predictable revenue. (Clearly Acquired, 2026; Sofer Advisors, 2026) Buyers discount the small ones because the income walks out the door the day the owner does.
The premium hiding in plain sight
Here’s the part most clinicians are never told. The biggest lever on what a clinic is worth isn’t how busy it is — it’s how predictable its revenue is. Businesses with recurring, subscription-style income are valued like assets, not jobs. Companies with 80%+ recurring revenue routinely trade at 6–12× EBITDA, while transactional models stay closer to 2–4× — roughly two to three times the multiple, for the same earnings. (Collaborative Commercial, 2025; Sofer Advisors, 2026; Stripe, 2023) Same earnings. Very different price tag.
Same EBITDA. Recurring revenue. Two to three times the valuation.
It holds inside healthcare, too. Larger platforms with recurring revenue and diversified, predictable earnings regularly reach 8–10× EBITDA and beyond — far above the 2–4× of a small, owner-dependent practice. (First Page Sage, 2025; Sofer Advisors, 2025)
Why longevity is the vehicle
Adding recurring revenue to a clinic isn’t a slogan — it needs something patients will gladly pay for, every month, for years. Longevity care is that something. The 55–75 demographic is the most motivated and able to invest in their healthspan, and a longevity patient has a high lifetime value: they don’t come once, they stay. That high LTV is also why the acquisition math works — the return on ad spend for longevity patients runs well above the ~3–4× healthcare advertising benchmark, because each patient is worth far more over time. (Webmarketing International, 2026; Netpeak, 2025) The same pattern shows up next door: in aesthetic and premium clinics, membership and loyalty models measurably raise both revenue stability and lifetime value. (Esthetic Academy, 2025; Gianos Agency, 2026; Stripe, 2023)
The transformation, in plain terms
Turning a clinic from a job into an asset comes down to a few moves: make the real economic activity visible on the books, fill the capacity you’re already paying for, and layer in recurring revenue through memberships, measurement, and high-margin services. Do that, and two things happen at once — your monthly income becomes predictable, and the whole business gets repriced: from a multiple of furniture to a multiple of what it actually earns.
It’s the same shift reshaping the whole sector. With private-clinic margins under pressure, consolidation increasingly favours groups that can industrialize predictable, recurring revenue — which is exactly the position an independent clinic can build for itself, early. (DREES, 2025; France-Épargne, 2025)
Why I build on this
This is the foundation under everything we do — not a marketing angle, but an economic reality I lived as an osteopath and proved in my own clinic. The technology, the patients, the recurring programs all exist for one purpose: to move a clinic out of the 2–3× world and into the 6–12× one. The longevity is how. The better exit is why.
Practice & healthcare valuation multiples
- Peak Business Valuation — “Valuation Multiples for a Medical Practice” (2023) & “Valuation Multiples for Chiropractic Clinics” (2024).
- Clearly Acquired — “Average EBITDA Multiples for Healthcare and Medical Practices” (2026).
- Sofer Advisors — “EBITDA Multiple for Business Valuation by Industry” (2026); “Medical Practice Valuation Multiples 2025–2026 Complete Guide” (2025).
- First Page Sage — “Healthcare EBITDA & Valuation Multiples: 2025 Report” (2025).
Recurring revenue & valuation
- Collaborative Commercial — “Why Recurring Revenue is More Valuable Than Regular Revenue” (2025).
- Stripe — “Guide to recurring revenue models / Billing” (2023).
Advertising ROAS benchmarks (healthcare)
- Webmarketing International — “What Is a Good ROAS? Benchmarks by Industry for 2026” (2026).
- Netpeak — “Know the ROI of PPC Campaigns in the Healthcare Industry” (2025).
Recurring & membership models in clinics
- Esthetic Academy — “Créer un modèle de rentabilité fondé sur la fidélisation dans l’esthétique professionnelle” (2025).
- Gianos Agency — “Comment les cliniques premium créent des revenus répétés” (2026).
Macro context & valuation primers
- DREES — “La situation économique et financière des cliniques privées à but lucratif” (2025).
- France-Épargne — “Marché des cliniques privées en France” (2025).
- XVAL — “Multiple d’EBITDA ou EBE et valorisation par secteur” (2024).
- Financyal — “Multiples de valorisation d’entreprise (EBE, EBIT, PER) en 2026” (2026).
Figures are industry benchmarks drawn from the sources above — illustrative, not a guarantee of a specific outcome for any individual clinic.